Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.96 EUR | 0.00% | -0.80% | -22.50% |
2023 | Noratis AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Noratis AG Announces Board Changes | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Real Estate Development & Operations
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.50% | 38.82M | - | ||
-9.36% | 22.5B | A- | ||
+9.02% | 10.79B | - | B- | |
-34.32% | 10.32B | B+ | ||
-28.99% | 7.2B | - | B+ | |
-5.56% | 7.01B | C- | ||
-0.34% | 6.53B | C+ | ||
-3.03% | 6.09B | A- | ||
+12.96% | 3.57B | - | ||
-5.92% | 3.54B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NUVA Stock
- NUVA Stock
- Ratings Noratis AG